New German study below.
T4 is cancer that has spread to nearby organs.
"To determine the outcomes of complete surgical resection of T4 prostate cancer (PCa) after inductive androgen deprivation treatment (ADT). An inductive ADT and subsequent radical prostatectomy (RP) is not recommended by any guideline yet."
"We retrospectively identified 116 patients treated between 2000 and 2014. At the time of diagnosis, median PSA was 37.6 ng/ml (range: 2.44-284 ng/ml). The preoperative median PSA after inductive ADT was 0.73 ng/ml (range: 0.01-34 ng/ml). Thereafter, patients underwent RRP {radical prostatectomy} or, since 2006, RALP {robot-assisted laparoscopic prostatectomy }. The median overall survival was 156 mo .... The cancer-specific survival at 150 months was 82%."
-Patrick
ncbi.nlm.nih.gov/pubmed/297...
BJU Int. 2018 May 17. doi: 10.1111/bju.14393. [Epub ahead of print]
Radical prostatectomy in T4 prostate cancer after inductive androgen deprivation: Results of a single-institution series with long-term follow up.
Hajili T1, Ohlmann CH1, Linxweiler J1, Niklas C1, Janssen M1, Siemer S1, Stoeckle M1, Saar M1.
Author information
1
Department of Urology and Pediatric Urology, Saarland University, Homburg/Saar, Germany.
Abstract
OBJECTIVES:
To determine the outcomes of complete surgical resection of T4 prostate cancer (PCa) after inductive androgen deprivation treatment (ADT). An inductive ADT and subsequent radical prostatectomy (RP) is not recommended by any guideline yet.
PATIENTS AND METHODS:
A monocentric RP database was queried for patients initially diagnosed with T4 PCa, considered as primary inoperable because of a fixed mass defined by rectal examination in combination with high PSA and/or large foci of biopsy-proven undifferentiated PCa. Treatment consisted of primary ADT until PSA nadir with consecutive prostatectomy. Patients underwent retropubic radical prostatectomy (RRP) or robot-assisted laparoscopic prostatectomy (RALP) after inductive ADT until achievement of the PSA nadir, which is in general reached after 6-7 months. The intraoperative course and complications were analysed. Finally, Kaplan-Meier estimates were calculated for overall and prostate-cancer specific survival.
RESULTS:
We retrospectively identified 116 patients treated between 2000 and 2014. At the time of diagnosis, median PSA was 37.6 ng/ml (range: 2.44-284 ng/ml). The preoperative median PSA after inductive ADT was 0.73 ng/ml (range: 0.01-34 ng/ml). Thereafter, patients underwent RRP or, since 2006, RALP. The median overall survival was 156 mo (95% CI, 118.9-193.1). The cancer-specific survival at 150 months was 82%.
CONCLUSIONS:
Surgical therapy of primarily inoperable PCa is feasible and safe after inductive ADT. Overall survival of this cohort seems comparable with results described for patients with primary operable high risk PCa. This article is protected by copyright. All rights reserved.
This article is protected by copyright. All rights reserved.
KEYWORDS:
Inductive androgen deprivation; inoperable high risk prostate cancer; prostate specific antigen nadir; radical prostatectomy
PMID: 29772100 DOI: 10.1111/bju.14393